2019 LMG Life Sciences research has officially begun!
March 22, 2019
Now accepting firm surveys and partner interviews
US
Corporate
| Corporate — Highly Recommended |
|---|
| Cooley |
| Goodwin Procter |
| Latham & Watkins |
| Morgan Lewis & Bockius |
| Ropes & Gray |
| Sidley Austin |
| WilmerHale |
| Corporate — Recommended |
|---|
| Arnold & Porter |
| Covington & Burling |
| Dechert |
| Gibson Dunn & Crutcher |
| Hogan Lovells |
| Jones Day |
| Morrison & Foerster |
| Wilson Sonsini Goodrich & Rosati |
Hatch-Waxman Patent Litigation (Generic)
| Hatch-Waxman Patent Litigation (Generic) — Highly recommended |
|---|
| Goodwin Procter |
| Knobbe Martens |
| Rakoczy Molino Mazzochi Siwik |
| Sterne Kessler Goldstein & Fox |
| Wilson Sonsini Goodrich & Rosati |
| Winston & Strawn |
| Hatch-Waxman Patent Litigation (Generic) — Recommended |
|---|
| Greenberg Traurig |
| Latham & Watkins |
| Morrison & Foerster |
| Perkins Coie |
| Robins Kaplan |
| Rothwell Figg Ernst & Manbeck |
| Taft Stettinius & Hollister |
| Willkie Farr & Gallagher |
Licensing & Collaboration
| Licensing & Collaboration — Highly Recommended |
|---|
| Cooley |
| Covington & Burling |
| Goodwin Procter |
| Hogan Lovells |
| Latham & Watkins |
| Morgan Lewis & Bockius |
| Ropes & Gray |
| WilmerHale |
| Wilson Sonsini Goodrich & Rosati |
| Licensing & Collaboration — Recommended |
|---|
| Dechert |
| Fenwick & West |
| Jones Day |
| King & Spalding |
| Mintz Levin Cohn Ferris Glovsky and Popeo |
| Sidley Austin |
| Wiggin and Dana |
Patent Prosecution
Patent Strategy & Management
| Patent Strategy and Management-Highly recommended |
|---|
| Choate Hall & Stewart |
| Cooley |
| Fenwick & West |
| Finnegan Henderson Farabow Garrett & Dunner |
| Fish & Richardson |
| Goodwin Procter |
| Knobbe Martens |
| Marshall Gerstein & Borun |
| Morrison & Foerster |
| Wilson Sonsini Goodrich & Rosati |
| Wolf Greenfield & Sacks |
Venture Capital
| Venture Capital — Highly Recommended |
|---|
| Cooley |
| Goodwin Procter |
| Latham & Watkins |
| Wilson Sonsini Goodrich & Rosati |
| Venture Capital — Recommended |
|---|
| Gunderson Dettmer |
| Hogan Lovells |
| Mintz Levin Cohn Ferris Glovsky and Popeo |
| Morgan Lewis & Bockius |
| Ropes & Gray |
| WilmerHale |
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Carsten, Douglas | |||
| Clark, Kenneth A | Financial & Corporate | Mergers & Acquisitions | Palo Alto, San Diego |
| Creighton, Susan | Non-IP Litigation & Enforcement | Antitrust | Washington, D.C. |
| Edvalson, Ian | Financial & Corporate | Licensing & Collaboration, Mergers & Acquisitions, Venture Capital | Palo Alto |
| Guise, Jeffrey W | Intellectual Property | General Patent Litigation | San Diego |
| Heslin, James M | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Palo Alto |
| Ishii, Robert T | Financial & Corporate | Mergers & Acquisitions | San Francisco |
| Koeppen, Dan | Financial & Corporate | Corporate, Mergers & Acquisitions | San Diego |
| McGlynn, J Casey | Financial & Corporate | Corporate, Mergers & Acquisitions, Venture Capital | Palo Alto |
| Norviel, Vern | Intellectual Property | Patent Prosecution, Patent Strategy & Management | San Francisco |
| Silber, Seth | Non-IP Litigation & Enforcement | Antitrust, White-Collar/Govt. Investigations | Washington, D.C. |
| Waters, Martin J | Financial & Corporate | Corporate, Licensing & Collaboration, Mergers & Acquisitions, Venture Capital | San Francisco |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Financial & Corporate
Wilson Sonsini Goodrich & Rosati
Wilson Sonsini Goodrich & Rosati has a dominant West Coast practice with deep expertise in the financial and corporate space. A competitor considers the firm's venture capital practice to be on "a level of [its] own." The firm also focuses on licensing agreements and collaborations as well as corporate transactions for life sciences companies. A client praises the group's capabilities, saying it offers "very deep experience [in the] biotech industry, and tremendous deal experience as well."
Co-leader of the technology transactions department Ian Edvalson frequently counsels companies on licensing agreements and strategic collaborative transactions. Edvalson's practice is particularly focused on the biopharmaceutical and biotechnology industries.
Kenneth Clark is a longstanding partner in the practice, with broad expertise in the financial area. "[He's been] doing this a long time," one peer says. Clark is experienced in handling licensing agreements and collaborations in addition to representing companies in financings and other corporate matters. San Francisco-based Robert Ishii is another deeply experienced member of the firm's financial and corporate team. According to a peer who frequently opposes Ishii, he is a "really strong" competitor, particularly in M&A.
Handling the firm's high volume of venture capital and corporate transactions are partners Dan Koeppen, Casey McGlynn, and Martin Walters, each especially experienced in IPOs and financings for emerging growth companies.
Intellectual Property
Wilson Sonsini Goodrich & Rosati
Wilson Sonsini Goodrich & Rosati is well known for its work in patent prosecution and portfolio strategy with a business-savvy focus. The firm has a strong presence in the Bay Area and has deep experience representing emerging and mid-size companies. This year Wilson Sonsini received a top ranking in Hatch-Waxman litigation for its practice representing generic pharmaceutical clients.
James Heslin is referred to as the "grandfather of the medical device world" by a peer, an area he has practiced in for more than two decades. He specializes in patent procurement, portfolio management, opinions, due diligence and licensing agreements, among other areas. Vern Norviel is head of the firm's patent counseling practice, and is one of Wilson Sonsini's top IP strategists. He advises life sciences clients in areas including diagnostics, therapeutics, nanotechnology and personalized medicine. In addition to his deep experience as a legal professional in private practice, he also has an in-house background as general counsel for a biotechnology company. Jeffrey Guise is a partner in the firm's San Diego office, where he offers clients services in patent procurement, licensing agreements and opinions.
Douglas Carsten was added to the firm's star roster this year for his work as one of Wilson Sonsini's involved Hatch-Waxman litigators. He notably represented Mylan in a high-profile suit against Allergan where he was successful in invalidating all patents covering the opponent's drug Restasis. This year he was shortlisted for the Generic Hatch-Waxman Litigator of the Year Award by LMG Life Sciences.
Articles
Now accepting firm surveys and partner interviews